Test Price
2,800 AED✅ Home Collection Available
CTC1 Gene Sequencing (Coat Plus Syndrome) Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين CTC1 لمتلازمة كوت بلس (التسلسل الجيني من الجيل التالي) في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary / الملخص التنفيذي
99.9% Diagnostic Sensitivity via ISO 9001:2015 accredited NGS processing (Cert: INT/EGQ/2509DA/3139). Home collection 8AM–11PM by certified phlebotomists using cold-chain logistics. Post-test telephonic clinical guidance included.
حساسية تشخيصية 99.9% عبر تقنية التسلسل الجيني من الجيل التالي المعتمدة من ISO 9001:2015. خدمة السحب المنزلي من 8 صباحاً حتى 11 مساءً مع سلسلة تبريد محكمة. استشارة طبية هاتفية بعد النتيجة.
Insurance & Verification: Direct billing support via WhatsApp +971 54 548 8731. Price: 2800 AED inclusive of genetic counselling session and comprehensive clinical report.
Test Overview
The CTC1 Gene NGS Test analyzes the entire coding sequence of the CTC1 gene using Next Generation Sequencing to diagnose Coat Plus syndrome (cerebroretinal microangiopathy with calcifications and cysts – CRMCC) and related telomere biology disorders. This definitive genetic assay identifies pathogenic variants with 99.9% sensitivity, guiding ophthalmologic, neurological, and systemic management for families across the UAE. (تحليل جين CTC1 بتقنية NGS لتشخيص متلازمة كوت بلس وجميع الاضطرابات المرتبطة بالقسيم الطرفي.)
| Feature | Our Test (Premium) | Closest Alternative |
|---|---|---|
| Methodology | NGS (Next Generation Sequencing) – full gene analysis | Sanger sequencing of select exons |
| Diagnostic Precision | 99.9% sensitivity, detects novel variants, CNVs | ~85% sensitivity, may miss deep intronic mutations |
| Turnaround Time | 3–4 weeks with clinical interpretation | 4–6 weeks |
| Regulatory Compliance | ISO 9001:2015, DHA/MOHAP licensed (Facility: 9834453) | Variable |
Physician Insight & Safety Protocol
Dr. Prabhakar Reddy (DHA License: 61713011) notes: “This test provides crucial molecular confirmation for patients with retinal vascular anomalies, intracranial calcifications, or systemic features suggestive of CRMCC. Clinical correlation with a thorough ophthalmologic examination and neurological imaging remains essential; a negative result does not exclude all genetic etiologies. I strongly advise discussing results with a geneticist to integrate findings into a personalized care plan.”
Do not discontinue prescribed medication without consulting your doctor. This test is a diagnostic adjunct, not a substitute for clinical monitoring.
Safety Box – Exclusion Criteria & Red Flags
- Exclusion: Patients with active infection, coagulopathy (INR >1.5), or platelet count <50,000/µL require alternative sampling method (FTA card / extracted DNA).
- Red Flags: Sudden vision loss, acute intracranial hypertension, or new-onset seizures demand immediate emergency care, not a scheduled genetic test. Proceed only when medically stable.
- Pediatric Collection: For minors (<18 years), CDS Law 2026 mandates legal guardian consent and a genetic counselling session prior to testing. Our team verifies compliance before appointment.
Frequently Asked Questions
Q: How is the test performed and what sample types are accepted?
A: We require either a minimally invasive whole blood sample (4 mL EDTA tube), extracted DNA, or a single drop of blood on an FTA card; our mobile phlebotomist collects the sample at your home and transports it in a validated cold-chain system to our ISO-certified lab. (يمكن استخدام عينة دم كامل، حمض نووي مستخلص، أو بقعة دم على بطاقة FTA.)
Q: What preparation is needed before the?
A: No fasting is required, but you must provide a detailed clinical history and attend a 30-minute genetic counselling session where a pedigree chart of affected family members will be drawn; this is mandatory for accurate result interpretation. (يجب تقديم تاريخ طبي كامل وجلسة استشارة وراثية إلزامية قبل الفحص.)
Q: What do the results mean and who should interpret them?
A: A positive result confirms a diagnosis of Coat Plus syndrome with a specific pathogenic variant, enabling targeted surveillance for retinal, neurological, and systemic complications; always review with your ophthalmologist and a medical geneticist. (النتيجة الإيجابية تؤكد التشخيص وتوجه المتابعة الطبية الدورية.)
Compliance: This service adheres to Federal Decree-Law No. 41 of 2024 (Art. 87), UAE PDPL data privacy standards, and Child Data Safety (CDS) Law 2026 for minors. Laboratory holds ISO 9001:2015 certificate INT/EGQ/2509DA/3139. All genetic data is stored and handled according to UAE healthcare regulations.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians